Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-105919
Filing Date
2025-11-04
Accepted
2025-11-04 07:25:48
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20250930x10q.htm   iXBRL 10-Q 1936802
2 EX-3.1 ocul-20250930xex3d1.htm EX-3.1 78779
3 EX-31.1 ocul-20250930xex31d1.htm EX-31.1 11939
4 EX-31.2 ocul-20250930xex31d2.htm EX-31.2 8378
5 EX-32.1 ocul-20250930xex32d1.htm EX-32.1 4943
6 EX-32.2 ocul-20250930xex32d2.htm EX-32.2 4934
  Complete submission text file 0001104659-25-105919.txt   7647018

Data Files

Seq Description Document Type Size
7 EX-101.SCH ocul-20250930.xsd EX-101.SCH 49787
8 EX-101.CAL ocul-20250930_cal.xml EX-101.CAL 52824
9 EX-101.DEF ocul-20250930_def.xml EX-101.DEF 223820
10 EX-101.LAB ocul-20250930_lab.xml EX-101.LAB 386212
11 EX-101.PRE ocul-20250930_pre.xml EX-101.PRE 333019
79 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20250930x10q_htm.xml XML 1250599
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 251446452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)